JK, O., NP, v. E., DM, B., AA, d. B., SLW, K., ADR, H., & R, T. H. (2025). Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib. Clinical pharmacokinetics, 64(3), 425. https://doi.org/10.1007/s40262-025-01480-w
Chicago Style (17th ed.) CitationJK, Overbeek, van Erp NP, Burger DM, den Broeder AA, Koolen SLW, Huitema ADR, and Ter Heine R. "Population Pharmacokinetics of Cobicistat and Its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib." Clinical Pharmacokinetics 64, no. 3 (2025): 425. https://doi.org/10.1007/s40262-025-01480-w.
MLA (9th ed.) CitationJK, Overbeek, et al. "Population Pharmacokinetics of Cobicistat and Its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib." Clinical Pharmacokinetics, vol. 64, no. 3, 2025, p. 425, https://doi.org/10.1007/s40262-025-01480-w.